CVS: Q3 growth lifts FY26 adjusted EPS guidance to at least $8.20

What happened

CVS reported third-quarter revenue growth of 5.4% and adjusted earnings per share, meaning profit per share excluding certain items, of $2.09. It raised its full-year adjusted earnings-per-share guidance to at least $8.20, reported improved performance in Health Care Benefits and Pharmacy and Consumer Wellness, and planned share repurchases in the fourth quarter.

Confirmed

Global impact / market context

Higher guidance signals that CVS expects stronger adjusted profit for the year than previously indicated. If that outlook is achieved, it could support investor expectations for earnings; planned share repurchases would use cash to buy back shares, potentially reducing the number of shares among which profits are divided.

Analyst inference

The reported revenue increase and improved segment performance provide operating context for the higher earnings outlook, while the planned buybacks are a separate use of cash. The supplied article gives no prior guidance, forecast comparisons, share price movement, or repurchase amount to gauge the scale of the change.

Analyst inference

What to watch

1. Watch later results for whether revenue growth and improved performance in Health Care Benefits and Pharmacy and Consumer Wellness continue to support the raised full-year earnings outlook. Analyst inference
2. Look for details on the planned fourth-quarter share repurchases, including how much cash CVS allocates, since the article gives no amount or execution schedule. Analyst inference
3. Compare reported full-year adjusted earnings per share with the at-least $8.20 guidance; falling short could weaken the earnings outlook implied by the update. Analyst inference

Evidence

• Original source link unavailable